| ViraEpi4269 | Epstein barr virus (EBV) | Rp | NA | 106229 | 106229 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4270 | Epstein barr virus (EBV) | Rp | NA | 106238 | 106238 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4271 | Epstein barr virus (EBV) | Rp | NA | 106276 | 106276 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4281 | Epstein barr virus (EBV) | Rp | NA | 106576 | 106576 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4282 | Epstein barr virus (EBV) | Rp | NA | 106634 | 106634 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4283 | Epstein barr virus (EBV) | Rp | NA | 106647 | 106647 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4285 | Epstein barr virus (EBV) | Rp | NA | 106660 | 106660 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4935 | Hepatitis B virus (HBV) | Polymerase gene | CpG Island III | 2242 | 2242 | Intermediate | 50% | Liver tissue samples | NA | 12 patients | Hepatocellular carcinoma (HCC) | BS-PCR | 26000761 | | ViraEpi4936 | Hepatitis B virus (HBV) | Polymerase gene | CpG Island III | 2266 | 2266 | Intermediate | 50% | Liver tissue samples | NA | 12 patients | Hepatocellular carcinoma (HCC) | BS-PCR | 26000761 | | ViraEpi4940 | Hepatitis B virus (HBV) | Polymerase gene | CpG Island III | 2354 | 2354 | Intermediate | 50% | Liver tissue samples | NA | 12 patients | Hepatocellular carcinoma (HCC) | BS-PCR | 26000761 | | ViraEpi4941 | Hepatitis B virus (HBV) | Polymerase gene | CpG Island III | 2385 | 2385 | Intermediate | 50% | Liver tissue samples | NA | 12 patients | Hepatocellular carcinoma (HCC) | BS-PCR | 26000761 | | ViraEpi4942 | Hepatitis B virus (HBV) | Polymerase gene | CpG Island III | 2396 | 2396 | Intermediate | 50% | Liver tissue samples | NA | 12 patients | Hepatocellular carcinoma (HCC) | BS-PCR | 26000761 | | ViraEpi4943 | Hepatitis B virus (HBV) | Polymerase gene | CpG Island III | 2409 | 2409 | Intermediate | 50% | Liver tissue samples | NA | 12 patients | Hepatocellular carcinoma (HCC) | BS-PCR | 26000761 | | ViraEpi4944 | Hepatitis B virus (HBV) | Polymerase gene | CpG Island III | 2412 | 2412 | Intermediate | 50% | Liver tissue samples | NA | 12 patients | Hepatocellular carcinoma (HCC) | BS-PCR | 26000761 | | ViraEpi4945 | Hepatitis B virus (HBV) | Polymerase gene | CpG Island III | 2414 | 2414 | Intermediate | 50% | Liver tissue samples | NA | 12 patients | Hepatocellular carcinoma (HCC) | BS-PCR | 26000761 |